Flow cytometry for the diagnosis of mycosis fungoides

Giornale Italiano di Dermatologia e Venereologia

Volumn 143, Issue 1, 2008, Pages 20-41

  Meyerson, H J ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; Lymphoma, T cell, cutaneous; Mycosis fungoides

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT RECEPTOR; HLA ANTIGEN; LYMPHOCYTE ANTIGEN;

BIOTECHNOLOGY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FLOW CYTOMETRY; GENETIC HETEROGENEITY; HEMATOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MYCOSIS FUNGOIDES; NEOPLASM; PHENOTYPE; REVIEW; SEZARY CELL; SKIN BIOPSY; T LYMPHOCYTE;

EID: 84912147040     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. Kim H, Hoppe R. Mycosis Fungoides and the Sezary Syndrome. Semin Oncol 1999;26:276-89.
2. Hoppe R, Wood G, Abel E. Mycosis Fungoides and the Sezary Syndrome: Pathology, Staging, and Treatment. Curr Probl Cancer 1990;14:295-371.
3. Rijlaarsdam J, Willemze R. Cutaneous Pseudolymphomes: Classification and differential diagnosis. Semin Dermatol 1994;13:187-96.
4. Grange F, Wechsler J, Guillaume JC, Tortel J, Tortel MC, Audhuy B et al. Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B cell lymphoma. J Am Acad Dermatol 2002;47:530-4.
5. Santucci M, Biggeri A, Feller AC, Burg G. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol 2000;136:497-502.
6. Pimpinelli N, Olsen E, Santucci M, Vonderheid E, Haeffner A, Stevens S et al. Defining early mycosi fungoides. J Am Acad Dermatol 2005;53:1053-63.
7. Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hemelink H, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
8. Wood G, Tung R, Haeffner A, Crooks C, Liao S, Orozco R et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994;103:34-41.
9. Bachelez H, Bioul L, Flageul B, Baccard M, Moulonguet-Michau I, Verola O et al. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome. Arch Dermatol 1995;131:1027-31.
10. Delfau-Larue M, Petrella T, Lahet C, Lebozec C, Bagot M, Roudot-Thoraval F et al. Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides. J Pathol 1998:184:185-90.
11. Delfau-Larue M, Dalac S, Lepage E, Petrella T, Wechsler J, Farcet J et al. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 1998;92:3376-80.
12. Ponti R, Quaglino P, Novelli M, Fierro M, Comessatty A, Peroni A et al. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol 2005;153:565-73.
13. Delfau-Larue M, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M et al. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000;96:2987-92.
14. Guitart J, Kaul K A new polymerase chain reaction-based method for the detection of T-cell clonality in patients with possible cutaneous T-cell lymphoma. Arch Dermatol 1999;135:158-62.
15. Scheller U, Muche JM, Sterry W, Lukowsky A. Detection of clonal T cells in cutaneous T cell lymphoma by polymerase chain reaction: comparison of mutation detection enhancement-polyacrylamide gel electrophoresis, temperature gradient gel electrophoresis and fragment analysis of sequencing gels. Electrophoresis 1998;19:653-8.
16. Li N, Bhawan J. New insights into the applicability of T-cell receptor gamma gene rearrangement analysis in cutaneous T-cell lymphoma. J Cutan Pathol 2001;28:412-8.
17. Florell S, Cessna M, Lundell R, Boucher K, Bowen G, Harris R. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol 2006;125:727-36.
18. Izban K, His E, Alkan S, Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections Mod Pathol 1998;11:978-82.
19. Wood G, Hong S, Sasaki D, Abel E, Hoppe R, Warnke R et al. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sezary syndrome relative to normal blood values. J Am Acad Dermatol 1990;22:602-7.
20. Balfour E, Glusac E, Heald P, Talley L, Smoller B. Sezary syndrome: cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity. J Cutan Pathol 2003;30:437-42
21. Freedman LJ, Maddox MT. A comparison of anti-biotin and biotinylated anti-avidin double-bridge and biotinylated tyramide immunohistochemical amplification. J Neurosci Methods 2001;112:43-9.
22. Meyerson H, Kaplan D. Applications of enzymatic amplification staining in immunophenotyping hematopoietic cells. Front Biosci 2002;7:c33-43.
23. Fukushima PI, Nguyen PK, O'Grady P, Stetler-Stevenson M. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry 1996;26:243-52.
24. Beck RC, Stahl S, O'Keefe CL, Maciejewski JP, Theil KS, Hsi ED. Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies Am J Clin Pathol 2003;120:785-94.
25. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, Boor PP, van Lochern EG, Hooijkaas H. Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood. 2001;98:165-73.
26. Schwab C, Willers J, Niederer E, Ludwig E, Kündig T, Grob P et al. The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol. 2002;118:1019-26.
27. Hunt SJ, Charley MR, Jegasothy BV. Cutaneous T-cell lymphoma: utility of antibodies to the variable regions of the human T-cell antigen receptor J Am Acad Dermatol 1992;26:552-8.
28. Weiss LM, Crabtree GS, Rouse RV, Warnke RA. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol. 1985;118:316-24.
29. Henni T, Gaulard P, Divine M, Le Couedic JP, Rocha D, Haioun C et al. Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases. Blood 988;72:1937-43.
30. Al Shanqeety O, Mourad WA. Diagnosis of peripheral T-cell lymphoma by fine-needle aspiration biopsy: a cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2000;23:375-9.
31. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990;2:229-40.
32. Weir EG, Cowan K, LeBeau P, Borowitz MJ. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia 1999;13:558-67.
33. Finn WG, Peterson LC, James C, Goolsby CL. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol 1998;110:341-6.
34. Wood B 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 2006;130:680-90.
35. Bromberg JE, Breems DA, Kraan J, Bikker G, van der Holt B, Smitt PS et al. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology 2007;68:1674-9.
36. Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer 2006;108:157-62.
37. Zander DS, Iturraspe JA, Everett ET, Massey JK, Braylan RC. Flow cytometry. In vitro assessment of its potential application for diagnosis and classification of lymphoid processes in cytologic preparations from fine-needle aspirates. Am J Clin Pathol 1994;101:577-86.
38. Fan K, Kelly R, Kendrick V. Nonclonal lymphocytic proliferation in cutaneous lymphoid hyperplasia: a flow-cytometric and morphological analysis. Dermatology 1992;185:113-9.
39. Singh NP.A rapid method for the preparation of single-cell suspensions from solid tissues. Cytometry 1998;31:229-32.
40. Burg G, Rodt H, Grosse-Wilde H, Braun-Falco O. Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol 1978;70:257-9.
41. Novelli M, Savoia P, Cambieri I, Ponti R, Comessatti A, Lisa F et al. Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. Clin Exp Dermatol 2000;25:423-31.
42. Yagi H, Seo N, Ohshima A, Itoh T, Itoh N, Horibe T et al. Chemokine Receptor Expression in Cutaneous T cell and NK/T-cell Lymphomas: Immunohistochemical Staining and In Vitro Chemotactic Assay. Am J Surg Pathol 2006;30:1111-9.
43. Daskalopoulou D, Galanopoulou A, Statiropoulou P, Papapetrou S, Pandazis I, Markidou S. Cytologically Interesting Cases of Primary Skin Tumors and Tumor-Like Conditions Identified by Fine-Needle Aspiration Biopsy Diag Cytopathol 1998;19:17-28.
44. Wu H, Smith M, Millenson M, Nicolaou N, Van Deerlin V, Addya K et al. Contribution of Flow Cytometry in the Diagnosis of Cutaneous Lymphoid Lesions. J Invest Dermatol 2003;121:1522-30.
45. Lee TK, Wiley AL Jr, Esinhart JD, Riley RS, Blackburn LD. Variations associated with disaggregation methods in DNA flow cytometry. Anal Quant Cytol Histol 1993;15:195-200.
46. Torres FX, Mackowiak PG, Brown RD, Linden MD, Zarbo RJ. Comparison of two methods of mechanical disaggregation of scirrhous breast adenocarcinomas for DNA flow cytometric analysis of whole cells. Am J Clin Pathol 1995;103:8-13.
47. Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, Shen Z et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001;166:877-84.
48. Humphreys T, Baldridge L, Billings A, Campbell J, Spinola S. Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with haemophilus ducreyi. Infect and Imm 2005;72:3896-902.
49. Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P et al. A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med. 2004;199:1265-75.
50. Belkaid Y, Jouin H, Milon G. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J Immunol Methods 1996;199:5-25.
51. Ford AL, Foulcher E, Goodsall AL, Sedgwick JD. Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J Immunol Methods 1996;194:71-5.
52. Tan RS, Byrom NA, Hayes JP. A method of liberating living cells from the dermal infiltrate.. Br J Dermatol 1975;93:271-6.
53. White HD, Prabhala RH, Humphrey SL, Crassi KM, Richardson JM, Wira CR. A method for the dispersal and characterization of leukocytes from the human female reproductive tract Am J Reprod Immunol 2000;44:96-103..
54. Kallinich T, Muche J, Qin S, Sterry W, Audring H, Kroczek R. Chemokine Receptor Expression on Neoplastic and Reactive T Cells in the Skin at Different Stages of Mycosis Fungoides. J Invest Dermatol 2003;121:1045-52.
55. Kleinhans M, Tun-Kyi A, Gilliet M, Kadin M, Dummer R, Burg G et al. Functional expression of the eotaxin receptor CCR3 in CD30 cutaneous T-cell lymphoma Blood. 2003;101:1487-93.
56. Qiu D, Tan W, Dithiothreitol has a dose-response effecton cell surface antigen expression. J Allergy Clin Immunol 1999;103:873-6.
57. Novelli M, Comessati A, Quaglino P, Savoia P, Fierro MT, Bernengo M. CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. Adv Exp Med Biol 2003;524:223-34.
58. Fierro MT, Comessatti A, Quaglino P, Ortoncelli M, Osella Abate S, Ponti R et al. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome. Dermatology 2006;213:284-92.
59. Ricevuti G, Mazzone A, Pasotti D, Degiulio R, Sacchi S. Flow cytometry analysis of T cell subsets in skin of patients with specific cutaneous manifestation of B non-Hodgkin lymphoma. Oncology 1991;48:180-3.
60. Oshtory S, Apisarnthanarax N, Gilliam AC, Cooper KD, Meyerson HJ.Usefulness of flow cytometry in the diagnosis of mycosis fungoides. J Am Acad Dermatol 2007;57:454-62.
61. Abuzakouk M, Feighery C, O'Farrelly C. Collagenase and Dispase enzymes disrupt lymphocyte surface molecules. J Immunol Methods 199;194:211-6
62. Fakhri O, Tan RS. The effect of trypsin on cell surface antigens. Cell Immunol 1975;15:452-6
63. Tan T. The effect of collagenase on surface markers of human peripheral lymphocytes. Br J Dermatol 1976;95:361-4.
64. Van Damme N, Baeten D, De Vos M, Demetter P, Elewaut D, Mielants H et al. Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. J Immunol Methods 2000;236:27-35.
65. Shapiro, H. Practical Flow Cytometry. New York, NY: Alan Liss Inc, 1985.
66. Keren D, McCoy J and Carey J. Flow Cytometry in Clinical Diagnosis. 3rd edition. Chicago, Ill, ASCP Press, 2001.
67. Gorczyca W. Flow Cytometry in Neoplastic Hematology. New York, NY: Taylor and Francis, 2006.
68. Nguyen D, Diamond L, Braylan R. Flow Cytometry in Hematopathology. 2nd edition. Totowa, NJ: Humana Press 2007.
69. Wood B and Borowitz M. the flow cytometric evaluation of hematopoietic neoplasia. In: McPherson R, Pincus M editors. Ed. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st edition. Philadelphia, PA: Saunders Elsevier; 2007. p. 599-616.
70. Kaplan D, Husel W, Meyerson H. Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining. Clin Lab Med. 2001;21:763-78.
71. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007;72(Suppl 1):S14-22.
72. Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996;26:16-21.
73. Yokote T, Akioka T, Oka S, Hara S, Kobayashi K, Nakajima H et al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 2005;124:199-204.
74. Wood GS, Abel EA, Hoppe RT, Warnke RA. Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Am Acad Dermatol 1986;14:1006-13.
75. Schmitt D, Souteyrand P, Brochier J, Czernielewski J, Thivolet J. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies. Acta Derm Venereol 1982;62:193-9.
76. Bergman R, Faclieru D, Sahar D, Sander CA, Kerner H, Ben-Aryeh Y et al. Immunophenotyping and T-cell receptor gamma gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoides. J Am Acad Dermatol 1998;39(4 Pt 1):554-9.
77. Abel E, Wood G, Hoppe R, Warnke R. Expression of Leu-8 antigen, a majority T cell marker, is uncommon in mycosis fungoides. J Invest Dermatol 1985;85:199-202.
78. Lu D, Patel KA, Duvic M, Jones D. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. J Cutan Pathol 2002;29:465-72.
79. Ralfkiaer E. Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol 1991;8:62-72.
80. Yagi H, Tokura Y, Furukawa F, Takigawa M. CD7-positive Sézary syndrome with a Th1 cytokine profile. J Am Acad Dermatol 1996;34:368-74.
81. Edelman J, Meyerson HJ. Diminished CD3 expression is useful for detecting and enumerating Sézary cells. Am J Clin Pathol 2000;114:467-77.
82. Morice WG, Katzmann JA, Pittelkow MR, el-Azhary RA, Gibson LE, Hanson CA. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome. Am J Clin Pathol 2006;125:364-74.
83. Lima M, Almeida J, dos Anjos Teixeira M, Queiros ML, Santos AH, Fonseca S et al. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome. Haematologica 2003;88:874-87.
84. Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S et al. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol 2001;44:456-61.
85. Laetsch B, Hȧffner AC, Döbbeling U, Seifert B, Ludwig E, Burg G et al. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol 2000;114:107-11.
86. Vonderheid EC, Bigler RD, Kotecha A, Boselli CM, Lessin SR, Bernengo MG et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol 2001;117:654-62.
87. Washington LT, Huh YO, Powers LC, Duvic M, Jones D. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2002;2:5-10.
88. Jones D, Dang NH, Duvic M, Washington LT, Huh YO. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885-92.
89. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001;144:125-35.
90. Scala E, Russo G, Cadoni S, Narducci MG, Girardelli CR, De Pità O et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J Invest Dermatol 1999;113:622-7.
91. Dummer R, Nestle FO, Niederer E, Ludwig E, Laine E, Grundmann H et al. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res 1999;291:307-11.
92. Bogen SA, Pelley D, Charif M, McCusker M, Koh H, Foss F et al. Immunophenotypic identification of Sezary cells in peripheral blood. Am J Clin Pathol 1996;106:739-48.
93. Harmon CB, Witzig TE, Katzmann JA, Pittelkow MR. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol 1996;35:404-10.
94. Kuchnio M, Sausville EA, Jaffe ES, Greiner T, Foss FM, McClanahan J et al. Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression. Am J Clin Pathol 1994;102:856-60.
95. Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol 1985;119:436-47.
96. Vonderheid EC, Bigler RD, Kotecha A, Boselli CM, Lessin SR, Bernengo MG et al. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol 2001;117:654-62.
97. Moll M, Reinhold U, Kukel S, Abken H, Müller R, Oltermann I et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol 1994;102:328-32.
98. Schimdt D, Goronzy JJ, Weyand CM. CD4+CD7-CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
99. Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. CD4+CD7-CD57+ T cells: a new T lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992;79:1746-53.
100. Vonderheid E, Bernengo M, Burg G, Duvic M, Heald P, Laroche L et al. Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas J Am Acad Derm 2002;46:95-106.
101. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Steitz J, Roszkiewicz J, Bieber T et al. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome. Clin Exp Dermatol 2005;30:702-6.
102. Kelemen K, Guitart J, Kuzel TM, Goolsby CL, Peterson LC. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. Am J Clin Pathol 2008;129:146-56.
103. Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS. Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. J Invest Dermatol 1989;93:116-20.
104. Ginaldi L, Matutes E, Farahat N, De Martinis M, Morula R, Catovsky D. Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry. Br J Haematol 1996;93:921-7.
105. Ginaldi L, Farahat N, Matutes E, De Martinis M, Morula R, Catovsky D. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry. J Clin Pathol 1996;49:539-44.
106. Poszepczynska-Guigné E, Schiavon V, D'Incan M, Echchakir H, Musette P, Ortonne N et al. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol 2004;122:820-3.
107. Ortonne N, Huet D, Gaudez C, Marie-Cardine A, Schiavon V, Bagot M et al. Significance of circulating T-cell clones in Sezary syndrome. Blood. 2006;107:4030-8.
108. Bahler DW, Hartung L, Hill S, Bowen GM, Vonderheid EC. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry. Cytometry B Clin Cytom. 2007 Dec 5 [Epub ahead of print].
109. Wechsler J, Bagot M, Nikolova M, Parolini S, Martin-Garcia N, Boumsell L et al. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes. J Pathol 2003;199:77-83.
110. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S et al. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005;152:258-64.
111. Capriotti E, Vonderheid EC, Thoburn CJ, Bright EC, Hess AD. Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations. J Invest Dermatol 2007;127:2882-92.
112. Narducci MG, Scala E, Bresin A, Caprini E, Picchio MC, Remotti D et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 2006;107:1108-15.
113. Wenzel J, Henze S, Wörenkämper E, Basner-Tschakarjan E, Sokolowska-Wojdylo M, Steitz J et al. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus. J Invest Dermatol 2005;124:1241-8.
114. Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood 2000;95:2212-8.
115. Wu H, Telang GH, Lessin SR, Vonderheid EC. Mycosis fungoides with CD30-positive cells in the epidermis. Am J Dermatopathol 2000;22:212-6.
116. Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ. Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res 2004;10:5587-94.
117. Schuurman HJ, van Wichen D, de Weger RA. Expression of activation antigens on thymocytes in the 'common thymocyte' stage of differentiation. Thymus 1989;14:43-53.
118. Puis M, Gatter KC, Mason DY. CD30 expression in follicular lymphoma. Histopathology 1991;18:25-9.
119. Miettinen M. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Arch Pathol Lab Med 1992;116:1197-201.
120. Sakaguchi S, Wing K, Miyara M. Regulatory T cells - a brief history and perspective. Eur J Immunol. 2007;37(Suppl 1):S116-23.
121. Dahmoush L, Hijazi Y, Barnes E, Stetler-Stevenson M, Abati A. Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study. Cancer 2002;96:110-6.
122. Ismail SA, Han R, Sanborn SL, Stevens SR, Cooper KD, Wood GS et al. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma. J Am Acad Dermatol 2007;56:635-42.
123. Richards SJ, Jones RA, Roberts BE, Patel D, Scott CS. Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes. Clin Exp Immunol 1990;81:149-55.
124. Fierro MT, Novelli M, Quaglino P, Comessatti A, Fava P, Ortoncelli M et al. Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma. Dermatology 2008;216:213-21.
125. Scala E, Narducci MG, Amerio P, Baliva G, Simoni R, Giovannetti A et al. T cell receptor-Vbeta analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sézary syndrome patients. J Invest Dermatol. 2002;119:193-6.
126. Attygalle A, Al-Jehani R, Diss T, Munson P, Liu H, Du M, Isaacson P et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002;99:627-33.
127. Lee P, Lin C, Chuang S. Immunophenotyping of angioimmunoblastic T-cell lymphomas by multiparameter flow cytometry. Pathol Res Pract 2003;199:539-45.
128. Attygalle AD, Diss TC, Munson P, Isaacson PG, Du MQ, Dogan A. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2004;28:54-61.
129. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A, Fabiani B et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006;30:490-4.
130. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5
131. Hedley DW, Shankey TV, Wheeless LL. DNA cytometry consensus conference. Cytometry 1993;14:471.
132. Pastel-Levy C, Flotte TJ, Preffer F, Ware A, Graeme-Cook F, Bell DA et al. Application of DNA flow cytometry from paraffin-embedded tissue to the diagnosis of mycosis fungoides. J Cutan Pathol 1991;18:279-83.
133. Wantzin GL, Larsen JK, Christensen IJ, Ralfkiaer E, Thomsen K. Early diagnosis of cutaneous T-cell lymphoma by DNA flow cytometry on skin biopsies. Cancer 1984;54:1348-52.
134. Bunn PA Jr, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest 1980;65:1440-8.
135. Lange Wantzin G, Larsen JK, Christensen IJ, Bruun Rasmussen B et al. Aneuploidy in cutaneous T-cell lymphoma. Acta Derm Venereol 1983;63:283-9.
136. Wang S, Li N, Heald P, Fisk JM, Fadare O, Howe JG et al. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue. Am J Clin Pathol 2004;122:774-82.
137. Ralfkiaer E, Larsen JK, Christensen IJ, Thomsen K, Wantzin GL. DNA analysis by flow cytometry in cutaneous T-cell lymphomas. Br J Dermatol 1989;120:597-605.
138. Smith PJ, Wiltshire M, Davies S, Patterson LH, Hoy T. A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry. J Immunol Methods 1999;229:131-9.
139. Jones D, Francisco V, Sarris AH et al. CD4-CD8- 'double-negative' cutaneous T cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol 2002;26: 225-31.
140. Hodak E, David M, Maron L, Aviram A, Kaganovsky E, Feinmesser M. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol 2006;55:276-84.
141. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999;155:483-92.
142. Fierro MT, Novelli M, Savoia P, Cambieri I, Quaglino P, Osella-Abate S et al. CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. J Cutan Pathol 2001;28:356-62.
143. Dunphy C, Nahass G. Primary cutaneous T cell rich B cell lymphomas with flow cytometric immunophenotypic findings. Arch Pathol Lab Med 1999;123:1236-40.